Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Current Assets: 2022-2024

Historic Current Assets for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Dec 2024 value amounting to $536.4 million.

  • Centessa Pharmaceuticals' Current Assets fell 45.87% to $307.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.7 million, marking a year-over-year decrease of 45.87%. This contributed to the annual value of $536.4 million for FY2024, which is 70.24% up from last year.
  • As of FY2024, Centessa Pharmaceuticals' Current Assets stood at $536.4 million, which was up 70.24% from $315.1 million recorded in FY2023.
  • Centessa Pharmaceuticals' Current Assets' 5-year high stood at $536.4 million during FY2024, with a 5-year trough of $315.1 million in FY2023.
  • Over the past 3 years, Centessa Pharmaceuticals' median Current Assets value was $437.7 million (recorded in 2022), while the average stood at $429.7 million.
  • Per our database at Business Quant, Centessa Pharmaceuticals' Current Assets declined by 28.02% in 2023 and then skyrocketed by 70.24% in 2024.
  • Over the past 3 years, Centessa Pharmaceuticals' Current Assets (Yearly) stood at $437.7 million in 2022, then dropped by 28.02% to $315.1 million in 2023, then skyrocketed by 70.24% to $536.4 million in 2024.